Preclinical ex vivo expansion of peripheral blood CD34+ selected cells from cancer patients mobilized with combination chemotherapy and granulocyte colony-stimulating factor

Vox Sanguinis

Volumn 94, Issue 4, 2008, Pages 342-350

  Lorenzon, D ^b   Mazzucato, M ^b   Abbruzzese, L ^b   Cilli, M ^c   De Angeli, S ^d   Degan, M ^b   Mambrini, G ^e   Piccardi, F ^c   Rupolo, M ^b   Michieli, M ^b   De Marco, L ^b   Gattei, V ^b   Astori, G ^a,e  

^a Cell Therapy Unit   (Switzerland)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d TREVISO REGIONAL HOSPITAL   (Italy)

^e Cyberonics Inc   (Italy)

Author keywords

Ex vivo expansion bioreactors; Haematopoietic stem cell transplantation; Peripheral blood

Indexed keywords

ANTIINFECTIVE AGENT; GRANULOCYTE COLONY STIMULATING FACTOR;

APOPTOSIS; ARTICLE; BLOOD; CANCER CHEMOTHERAPY; CANCER PATIENT; CD34 SELECTION; CELL EXPANSION; CELL POPULATION; CELL TRANSPLANTATION; CONTROLLED STUDY; ENGRAFTMENT; EWING SARCOMA; EX VIVO STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADULT; ANIMALS; ANTIGENS, CD34; CELL CULTURE TECHNIQUES; CELLS, CULTURED; FEASIBILITY STUDIES; FEMALE; GRAFT SURVIVAL; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKAPHERESIS; MALE; MICE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION;

EID: 42149126716     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2008.01038.x     Document Type: Article

References (36)

1. Shipp MA, Abeloff MD, Antman KH, Carroll G, Hagenbeek A, Loeffler M, Montserrat E, Radford JA, Salles G, Schmitz N, Symann M, Armitage JO, Philip T, Coiffier B : International consensus conference on high-dose therapy with hematopoietic stem cell transplantation in aggressive non-Hodgkin's lymphomas: report of the jury. J Clin Oncol 1999 17 : 423 429
2. Schrezenmeier H, Passweg JR, Marsh JC, Bacigalupo A, Bredeson CN, Bullorsky E, Camitta BM, Champlin RE, Gale RP, Fuhrer M, Klein JP, Locasciulli A, Oneto R, Schattenberg AVMB, Socie G, Eapen M : Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia. Blood 2007 110 : 1397 1400
3. De Bruyn C, Delforge A, Martiat P, Bron D : Ex vivo expansion of neutrophil precursor cells from mobilized peripheral blood cells: similar results in cancer patients and normal donors. Cytotherapy 2005 7 : 470 477
4. McNiece I, Jones R, Bearman SI, Cagnoni P, Nieto Y, Franklin W, Ryder J, Steele A, Stoltz J, Russell P, McDermitt J, Hogan C, Murphy J, Shpall EJ : Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer. Blood 2000 96 : 3001 3007
5. Glaspy JA, Shpall EJ, LeMaistre CF, Briddell RA, Menchaca DM, Turner SA, Lill M, Chap L, Jones R, Wiers MD, Sheridan WP, McNiece IK : Peripheral blood progenitor cell mobilization using stem cell factor in combination with filgrastim in breast cancer patients. Blood 1997 90 : 2939 2951
6. Scheding S, Franke H, Diehl V, Wichmann HE, Brugger W, Kanz L, Schmitz S : How many myeloid post-progenitor cells have to be transplanted to completely abrogate neutropenia after peripheral blood progenitor cell transplantation? Results of a computer simulation. Exp Hematol 1999 27 : 956 965
7. Scheding S, Meister B, Buhring HJ, Baum CM, Mc Kearn JP, Bock T, Kanz L, Brugger W : Effective ex vivo generation of granulopoietic postprogenitor cells from mobilized peripheral blood CD34(+) cells. Exp Hematol 2000 28 : 460 470
8. Hino M, Suzuki K, Yamane T, Sakai N, Kubota H, Koh K-R, Ohta K, Hato F, Kitagawa S, Tatsumi N : Ex vivo expansion of mature human neutrophils with normal functions from purified peripheral blood CD34+ haematopoietic progenitor cells. Br J Haematol 2000 109 : 314 321
9. Li K, Li CK, Chuen CK, Tsang KS, Fok TF, James AE, Lee SM, Shing MMK, Chik KW, Yuen PMP : Preclinical ex vivo expansion of G-CSF-mobilized peripheral blood stem cells: effects of serum-free media, cytokine combinations and chemotherapy. Eur J Haematol 2005 74 : 128 135
10. Szilvassy SJ, Weller KP, Chen B, Juttner CA, Tsukamoto A, Hoffman R : Partially differentiated ex vivo expanded cells accelerate hematologic recovery in myeloablated mice transplanted with highly enriched long-term repopulating stem cells. Blood 1996 88 : 3642 3653
11. Astori G, Larghero J, Bonfini T, Giancola R, Riti M, Rodriguez L, Rodriguez M, Mambrini G, Bigi L, Iacone A, Marolleau JP, Panzani I, Garcia J, Querol S : Ex vivo expansion of umbilical cord blood CD34+ cells in a closed system: a multicentric study. Vox Sang 2006 90 : 183 190
12. Astori G, Adami V, Mambrini G, Bigi L, Cilli M, Facchini A, Falasca E, Malangone W, Panzani I, Degrassi A : Evaluation of ex vivo expansion and engraftment in NOD-SCID mice of umbilical cord blood CD34+ cells using the DIDECO 'Pluricell System'. Bone Marrow Transplant 2005 35 : 1101 1106
13. Hogan CJ, Shpall EJ, McNulty O, McNiece I, Dick JE, Shultz LD, Keller G : Engraftment and development of human CD34(+)-enriched cells from umbilical cord blood in NOD/LtSz-scid/scid mice. Blood 1997 90 : 85 96
14. Dick JE : Normal and leukemic human stem cells assayed in SCID mice. Semin Immunol 1996 8 : 197 206
15. Conneally E, Cashman J, Petzer A, Eaves C : Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice. Proc Natl Acad Sci USA 1997 94 : 9836 9841
16. Qiu L, Meagher R, Welhausen S, Heye M, Brown R, Herzig RH : Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines. J Hematother Stem Cell Res 1999 8 : 609 618
17. Briddell RA, Kern BP, Zilm KL, Stoney GB, McNiece IK : Purification of CD34+ cells is essential for optimal ex vivo expansion of umbilical cord blood cells. J Hematother 1997 6 : 145 150
18. Douay L : Experimental culture conditions are critical for ex vivo expansion of hematopoietic cells. J Hematother Stem Cell Res 2001 10 : 341 346
19. Haylock DN, Horsfall MJ, Dowse TL, Ramshaw HS, Niutta S, Protopsaltis S, Peng L, Burrel C, Rapold I, Buhring H-J, Simmons PJ : Increased recruitment of haemopoietic progenitor cells underlies the ex vivo expansion potential of FLT3 ligand. Blood 1997 90 : 2260 2272
20. Hunnestad JA, Steen R, Tjonnfjord GE, Egeland T : Thrombopoietin combined with early-acting growth factors effectively expands human hematopoietic progenitor cells in vitro. Stem Cells 1999 17 : 31 38
21. Rossmanith T, Schroder B, Bug G, Müller P, Klenner T, Knaus R, Hoelzer D, Ottmann OG : Interleukin 3 improves the ex vivo expansion of primitive human cord blood progenitor cells and maintains the engraftment potential of scid repopulating cells. Stem Cells 2001 19 : 313 320
22. Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I : The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International society of hematotherapy and graft engineering. J Hematother 1996 5 : 213 226
23. Nissen-Druey C, Tichelli A, Meyer-Monard S : Human hematopoietic colonies in health and disease. Acta Haematol 2005 113 : 5 96
24. Haylock DN, To LB, Dowse TL, Juttner CA, Simmons PJ : Ex vivo expansion and maturation of peripheral blood CD34+ cells into the myeloid lineage. Blood 1992 80 : 1405 1412
25. Smith SL, Bender JG, Maples PB, Unverzagt K, Schilling M, Lum L, Williams S, Van Epps DE : Expansion of neutrophil precursors and progenitors in suspension cultures of CD34+ cells enriched from human bone marrow. Exp Hematol 1993 21 : 870 877
26. Lill MC, Lynch M, Fraser JK, Chung GY, Schiller G, Glaspy JA, Souza L, Baldwin GC, Gasson JC : Production of functional myeloid cells from CD34-selected hematopoietic progenitor cells using a clinically relevant ex vivo expansion system. Stem Cells 1994 12 : 626 637
27. Ivanovic Z, Duchez P, Dazey B, Hermitte F, Lamrissi-Garcia I, Mazurier F, Praloran V, Reiffers J, Vezon G, Boiron JM : A clinical-scale expansion of mobilized CD34+ hematopoietic stem and progenitor cells by use of a new serum-free medium. Transfusion 2006 46 : 126 131
28. EMEA : Guideline on Human Cell-Based Medicinal Products (draft); available at http://www.emea.europa.eu/pdfs/human/cpwp/41086906en.pdf
29. Molineux G, Hartley C, McElroy P, McCrea C, McNiece IK : Megakaryocyte growth and development factor accelerates platelet recovery in peripheral blood progenitor cell transplant recipients. Blood 1996 88 : 366 376
30. Jansen EM, Hanks SG, Terry C, Akard LP, Thompson JM, Dugan MJ, Jansen J : Prediction of engraftment after autologous peripheral blood progenitor cell transplantation: CD34, colony-forming unit-granulocyte-macrophage, or both? Transfusion 2007 47 : 817 823
31. Zanjani ED, Almeida-Porada G, Flake AW : The human/sheep xenograft model: a large animal model of human hematopoiesis. Int J Hematol 1996 63 : 179 192
32. Peters SO, Kittler EL, Ramshaw HS, Quesenberry PJ : Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts. Blood 1996 87 : 30 37
33. Szilvassy SJ, Meyerrose TE, Ragland PL, Grimes B : Homing and engraftment defects in ex vivo expanded murine hematopoietic cells are associated with downregulation of β1 integrin. Exp Hematol 2001 29 : 1494 1502
34. Danet GH, Lee HW, Luongo JL, Simon MC, Bonnet DA : Dissociation between stem cell phenotype and NOD/SCID repopulating activity in human peripheral blood CD34(+) cells after ex vivo expansion. Exp Hematol 2001 29 : 1465 1473
35. Prince HM, Simmons PJ, Whitty G, Wall DP, Barber L, Toner GC, Seymour JF, Richardson G, Mrongovius R, Haylock DN : Improved haematopoietic recovery following transplantation with ex vivo-expanded mobilized blood cells. Br J Haematol 2004 126 : 536 545
36. Boiron JM, Dazey B, Cailliot C, Launay B, Attal M, Mazurier F, McNiece IK, Ivanovic Z, Caraux J, Marit G, Reiffers J : Large-scale expansion and transplantation of CD34(+) hematopoietic cells: in vitro and in vivo confirmation of neutropenia abrogation related to the expansion process without impairment of the long-term engraftment capacity. Transfusion 2006 46 : 1934 1942